Genexine, Inc. (095700.KQ)

Genexine, Inc. (095700.KQ) — VMCI valuation read

Across 120 indicators, Genexine, Inc. (095700.KQ) lands at VMCI 31/100. The Healthcare sector median is 50, so the 19-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 095700.KQ in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 095700.KQ trades at 27.0x earnings, 50% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of -0.6x leaves covenant headroom for 095700.KQ on the trailing balance sheet.

095700.KQ rose 1.8% over the trailing 7 days, with a -21.4% read on a 30-day basis.